'Aggrecanase' activity is implicated in tumour necrosis factor mediated cartilage aggrecan breakdown but is not detected by an in vitro assay

Journal of Clinical Pathology - Molecular Pathology

Volumn 50, Issue 3, 1997, Pages 153-159

  Buttle, D J ^a   Fowles, A ^a   Ilic, M Z ^b   Handley, C J ^b  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

'Aggrecanase'; Aggrecan; Cartilage; Tumour necrosis factor

Indexed keywords

AGGRECAN; GLUTAMYL AMINOPEPTIDASE; PROTEOGLYCAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CATTLE; CHONDROLYSIS; CONTROLLED STUDY; CULTURE MEDIUM; DEGLYCOSYLATION; ENZYME ACTIVITY; ENZYME ASSAY; EXPLANT; NONHUMAN; NOSE CARTILAGE; PRIORITY JOURNAL;

EID: 0030687585     PISSN: 13668714     EISSN: None     Source Type: Journal    
DOI: 10.1136/mp.50.3.153     Document Type: Article

References (36)

1. Kempson GE, Tuke MA, Dingle JT, Barrett AJ, Horsfield PH. The effects of proteolytic enzymes on the mechanical properties of adult human articular cartilage. Biochem Biophys Acta 1976;428:741-60.
2. Hollander AP, Atkins RM, Eastwood DM, Dieppe PA, Elson CJ. Human cartilage is degraded by rheumatoid arthritis synovial fluid but not by recombinant cytokines in vitro. Clin Exp Immunol 1991;83:52-7.
3. Fell HB, Jubb RW. The effect of synovial tissue on the breakdown of articular cartilage in organ culture. Arthritis Rheum 1977;20:1359-71.
4. Saklatvala J, Pilsworth LMC, Sarsfield SJ, Gavrilovic J, Heath JK. Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J 1984;224:461-6.
5. Saklatvala J. Tumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322:547-9.
6. Buttle DJ, Handley CJ, Ilic MZ, Saklatvala J, Murata M, Burrett AJ. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation. Arthritis Rheum 1993;36:1709-17.
7. Buttle DJ, Bramwell H, Hollander AP. Proteolytic mechanisms of cartilage breakdown a target for arthritis therapy? J Clin Pathol: Mol Pathol 1995;48:M167-77.
8. Nixon JS, Bottomley KMK, Broadhurst MJ, Brown PA, Johnson WH, Lawton G, et al. Potent ollagenase inhibitors prevent interleukin 1-induced cartilage degradation in vitro. Int J Tiss Reac 1991;13:237-43.
9. Andrews HJ, Plumpton TA, Harper GP, Cawston TE. A synthetic peptide metalloproteinase inhibitor, but not Timp, prevents the breakdown of proteoglycan within articular cartilage in vitro. Agents Actions 1992;37:147-54.
10. Seed MP, Ismail S, Cheung CY, Thomson TA, Gardner CR, Atkins RM, et al. Inhibition of interleukin 1 beta induced rat and human cartilage degradation in vitro by the metalloproteinase inhibitor U27931. Ann Rheum Dis 1993; 52:37-43.
11. Brown CJ, Rahman S, Morton AC, Beauchamp CL, Bramwell H, Buttle DJ. Inhibitors of collagenase but not of gelatinase reduce curtilage expiant proteoglycan breakdown despite only low levels of matrix metalloproteinase activity. J Clin Pathol: Mol Pathol 1996;49:M133-9.
12. Sandy JD, Flannery CR, Neame PJ, Lohmander LS. The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond in the interglobular domain. J Clin Invest 1992;89:1512-6.
13. Lohmander LS, Neame PJ, Sandy JD. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease. Arthritis Rheum 1993;36:1214-22.
14. Sandy JD, Neame PJ, Boynton RE, Flannery CR. Catabolism of aggrecan in cartilage explants. J Biol Chem 1991;266:8683-5.
15. Ilic MZ, Handley CJ, Robinson HC, Mok MT. Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys 1992;294:115-22.
16. Loulakis P, Shrikhande A, Davis G, Magnilia CA. N-terminal sequence of proteoglycan fragments isolated from medium of interleukin-1 treated articular cartilage cultures. Putative site(s) of enzymic cleavage. Biochem J 1992;284:589-93.
17. Lark MW, Gordy JT, Weidner JR, Ayala J, Kimura JH, Williams HR et al. Cell-mediated catabolism of aggrecan. Evidence that cleavage at the aggrecanase cleavage site (Glu373-Ala374) is a primary event in proteolysis of the interglobular domain. J Biol Chem 1995;270:2550-6.
18. Plaas AHK, Sandy JD. A cartilage expiant system for studies on aggrecan structure, biosynthesis and catabolism in discrete zones of the mammalian growth plate. Matrix 1993;13:135-47.
19. Hughes CE, Caterson B, Fosang AJ, Roughley PJ, Mort JS. Monoclonal antibodies that specifically recognise neoepitope sequences generated by aggrecanase and matrix metalloproteinase cleavage of aggrecan: application to catabolism in situ and in vitro. Biochem J 1995;305:799-804.
20. Buttle DJ, Saklatvala J, Tamai M, Barrett AJ. Inhibition of interleukin 1-stimulated cartilage proteoglycan degradation by a lipophillic inactivator of cysteine endopeptidases. Biochem J 1992;281:175-7.
21. Holtzer H, Abbot J, Lash J, Holtzer S. The loss of phenotypic traits by differentiated cells in vitro. I. Dedifferentiation of cartilage cells. Proc Natl Acad Sci USA 1960;46:1533-42.
22. Farndale RW, Buttle DJ, Barrett AJ. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 1986; 883:173-7.
23. Handley CJ, Buttle DJ. Assay of proteoglycan degradation. Methods Enzymol 1995;248:47-58.
24. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
25. Couchman JR, Caterson B, Christner JH, Baker JR. Mapping by monoclonal antibody detection of glycosaminoglycans in connective tissues. Nature 1984;307: 650-2.
26. Howard L, Glynn P. Membrane-associated metalloproteinase recognized by characteristic cleavage of myelin basic protein: assay and isolation. Methods Enzymol 1995;248: 388-95.
27. Bunning RAD, Crawford A, Richardson HJ, Opdenakker G, van Damme J, Russell RGG. Interleukin 1 preferentially stimulates the production of tissue-type plasminogen activator by human articular chondrocytes. Biochim Biophys Acta 1987;924:473-82.
28. Kozaci LD, Buttle DJ, Hollander AP. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures. Arthritis Rheum 1996;40:164-74.
29. Rawlings ND, Barrett AJ. Evolutionary families of metallopeptidases. Methods Enzymol 1995;248:183-228.
30. McKie N, Dallas DJ, Edwards T, Apperley JF, Russell RGG, Croucher PI. Cloning of a novel membrane-linked metalloproteinase from human myeloma cells. Biochem J 1996;318:459-62.
31. Morris EA, Wilcon S, Treadwell BV. Inhibition of interleukin 1-mediated proteoglycan degradation in bovine articular cartilage explants by addition of sodium hyaluronate. Am J Vet Res 1992;53:1977-82.
32. Culty M, Nguyen HA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992;116:1055-62.
33. Ng CK, Handley CJ, Preston BN, Robinson HC. The extracellular processing and catabolism of hyaluronan in cultured adult articular cartilage explants. Arch Biochem Biophys 1992;298:70-9.
34. Ng CK, Handley CJ, Preston BN, Robinson HC, Bolis S, Parker G. Effect of exogenous hyaluronan and hyaluronan oligosaccharides on hyaluronan and aggrecan synthesis and catabolism in adult articular cartilage explants. Arch Biochem Biophys 1995;316:596-606.
35. Salter DM, Godolphin JL, Gourlay MS, Lawson MF, Hughes DE, Dunne E. Analysis of human articular chondrocyte CD44 isoform expression and function in health and disease. J Pathol 1996;179:396-402.
36. Chow G, Knudson CB, Homandberg G, Knudson W. Increased expression of CD44 in bovine articular chondrocytes by catabolic cellular mediators. J Biol Chem 1995;270:27734-41.